Nombre del producto:Benzo[d]thiazole-6-sulfonyl chloride

IUPAC Name:1,3-benzothiazole-6-sulfonyl chloride

CAS:181124-40-3
Fórmula molecular:C7H4ClNO2S2
Pureza:97%
Número de catálogo:CM158498
Peso molecular:233.68

Unidad de embalaje Stock disponible Precio($) Cantidad
CM158498-5g in stock džȤȤ
CM158498-10g in stock džȅȖ
CM158498-25g in stock Ɛdžȅ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :181124-40-3
Fórmula molecular:C7H4ClNO2S2
Punto de fusión:-
Código de sonrisas:O=S(C1=CC=C2N=CSC2=C1)(Cl)=O
Densidad:
Número de catálogo:CM158498
Peso molecular:233.68
Punto de ebullición:376.9°C at 760 mmHg
Nº Mdl:
Almacenamiento:Store in freezer, under -20°C.

Category Infos

Benzothiazoles
Benzothiazoles are aromatic heterocyclic compounds with the chemical formula C7H5NS. Benzothiazoles and their derivatives are a very important class of heterocyclic compounds that are ubiquitous in nature and are mainly used in medicine, agriculture and industry. In medicine, benzothiazole derivatives are a kind of very important pharmaceutical intermediates with good pharmacological and biological activities. It can be used as a fungicide, anti-tuberculosis drug, anti-malarial, anti-convulsant, insecticide, sedative and anti-inflammatory drug, and can also be used to treat diabetes and has anti-cancer effects.

Column Infos

Lanifibranor
Recently, Inventiva announced positive results of its interim analysis of the Phase II, Proof-of-Concept clinical trial, LEGEND, evaluating lanifibranor in combination with empagliflozin in patients with MASH/NASH and poorly controlled Type 2 Diabetes (T2D). The study achieved the primary efficacy endpoint. Lanifibranor is an orally-available small molecule pan PPAR agonist with a -wellbalanced- activation of PPARα and PPARδ, and a partial activation of PPARγ. Lanifibranor acts to induce anti fibrotic, anti-inflammatory and beneficial vascular and metabolic changes in the body.

Related Products